Paragraph 23 RecordsF1E1
England, Wales and Scotland
The holder of an authorisation under paragraph 14 must, as soon as is reasonably practicable after the product is supplied, in addition to the expiry date of the product, record the following—
in the case of an unauthorised veterinary medicinal product for administration under the cascade—
the name and address of the veterinary surgeon who ordered the veterinary medicinal product;
a precise description of the product;
the date of production;
the date of supply to the veterinary surgeon;
in the case of stem cells or blood—
the identification of the source animal;
the name of the veterinary surgeon who collected the product (or under whose responsibility it was collected);
the date of collection of the product;
the date that the product was used or if the product was supplied to another veterinary surgeon, the name and address of that veterinary surgeon and the date the product was supplied;
in the case of an autogenous vaccine—
the name and address of the veterinary surgeon who ordered the vaccine;
the identification of the source animal;
the date of supply to the veterinary surgeon,
and must keep the records for at least five years.
Annotations
Textual amendments
- F1
Sch. 2 Pt. 2 (paras. 14-25 entitled "Authorisation of autogenous vaccines, blood-banks, stem cell centres and products manufactured under the cascade") substituted for Sch. 2 Pt. 2 (paras. 14-19 entitled "Authorisation of manufacturers of autogenous vaccines"), Pt. 3 (paras. 20-24 entitled "Authorisation of blood banks"), Pt. 4 (paras. 25-29 entitled "Authorisation of manufacturers of products for administration under the cascade") and Pt. 5 (paras. 30-35 entitled "Authorisation of equine stem cell centres") (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 92
Extent
- E1
This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only